We have examined the multimeric composition of factor VIII/von Willebrand factor in plasma and platelet lysates by means of sodium dodecyl sulfate agarose electrophoresis followed by staining with 125 I-labeled affinity-purified antibody. In normal plasma and platelet lysates, factor VIII/von Willebrand factor displayed 10 distinct multimers that ranged in apparent molecular weight from 0.86 to 9.9 × 10 6 . The molecular weight difference between adjacent bands was 0.8−1.1 × 10 6 . Larger material, not resolved into discrete bands, was also present with an average M r of 14.5 × 10 6 . Though the dimer (apparent M r = 0.48 × 10 6 ) and the monomer (apparent M r = 0.28 × 10 6 ) generated by reduction of disulfide bonds were readily identified in this system, they were not detected in normal plasma or platelets. No differences were observed between fresh plasma prepared without anticoagulant and fresh or frozen plasma anticoagulated with either citrate or heparin. "Variant" (type II) von Willebrand's disease could be divided into two subtypes. In subtype IIA, factor VIII/von Willebrand factor in plasma consisted predominantly of the five smaller multimers with traces of the sixth and seventh (M r up to 4.5 × 10 6 ). In subtype IIB, all these multimers were easily detected and, in addition, bands of intermediate size (M r = 8.5 × 10 6 and smaller) were present. In contrast, the multimeric composition of IIB platelet […] Find the latest version:
A B S T R A C T We have examined the multimeric composition of factor VIII/von Willebrand factor in plasma and platelet lysates by means ofsodium dodecyl sulfate agarose electrophoresis followed by staining with 125I-labeled affinity-purified antibody. In normal plasma and platelet lysates, factor VIII/von Willebrand factor displayed 10 distinct multimers that ranged in apparent molecular weight from 0.86 to 9.9 x 106. The molecular weight difference between adjacent bands was 0.8-1.1 x 106. Larger material, not resolved into discrete bands, was also present with an average Mr of 14 .5 x 106. Though the dimer (apparent Mr = 0.48 x 106) and the monomer (apparent Mr = 0.28 x 106) generated by reduction of disulfide bonds were readily identified in this system, they were not detected in normal plasma or platelets. No (9) (10) (11) and SDS agarose gel electrophoresis (12) . These patients have a bleeding tendency and decreased ristocetin-induced platelet-FVIII/vWF interaction even when the overall concentration of FVIII/vWF in plasma is normal (11) . Thus, size distribution has appeared to be an important correlate of function. However, the identification of a subtype (IIB) of variant VWD with heightened ristocetin-induced FVIII/vWF platelet interaction (13) has suggested that variant VWD is not a homogeneous group, and differences in FVIII/vWF structure might be expected among the different patients.
We have now used a new technique for examining the multimeric composition of FVIII/vWF directly in plasma and platelet lysates without intervening purification steps. This technique demonstrates that FVIII/vWF is present in plasma and platelets as a series of polymers and suggests that the protomer has an apparent Mr of 0.86 x 106. Such a protomer would most closely correspond to a tetramer of the basic FVIII/vWF subunit. Moreover, the multimeric composition of FVIII/vWF differs in subtype IIB from other variants of VWD (subtype IIA) studied. This difference is seen both in plasma and in platelet lysates. These results, when taken in concert with ristocetin-induced FVIII/vWF platelet-binding studies, suggest that subtypes IIA and IIB are caused by different underlying pathogenetic mechanisms. Collection of blood and preparation of plasma. Blood was obtained from clean venipuncture through a 19-gauge needle and collected in plastic tubes containing 0.1 final vol of 3.8% trisodium citrate. In some experiments, blood was collected in heparin at a final concentration of 5 U/ml. Platelet-poor plasma was prepared by centrifugation at 4,000 g for 20 min at 20°C. Plasma was immediately separated and tested fresh or frozen at -70°C until used. Plasma samples to be analyzed in SDS agarose gel electrophoresis were mixed with 0.1 vol of 10% SDS immediately before testing. In some experiments, fresh native plasma was prepared by collecting blood directly into a plastic tube with no anticoagulant, followed by immediate centrifugation at 12,000 g for 2 min, addition of SDS, and electrophoresis. The sample was applied to the gel within 4 min of venipuncture. Addition of SDS to native plasma without anticoagulant prevented visible fibrin formation over a 24-h observation period. Similar samples without SDS showed fibrin formation usually within 20-40 min from venipuncture. 10 patients with variant VWD subtype IIB, which differed from subtype IIA by demonstrating increased instead of absent ristocetininduced platelet agglutination and measurable VIII:RCo A0.11-0.75 U/ml). Bleeding time was prolonged in all IIB patients, and the crossed immunoelectrophoretic pattern was indistinguishable from that of IIA patients (Fig. 1 ). This new subtype of VWD (IIB) has been characterized in a separate study (13) . Normal controls were 12 different volunteers of both sexes with no bleeding abnormality.
METHODS
Purification of FVIII/vWF. FVIII/vWF was purified from cryoprecipitate of fresh frozen plasma by means of agarose gel chromatography, as reported elsewhere (14) .
Preparation and diluted in 100 ml of veronal buffer to give -1 x 106 cpm in 1 ml. These antibodies were prepared as described previously (18) , with the exception that emus (kindly provided by the San Diego Zoo, San Diego, Calif.), as well as rabbits, were immunized. The gel was then washed in two changes of 0.5 NI NaCl for [4] [5] [6] (Fig. 3) . Moreover, purified FVIII/ vWF showed a multimeric composition identical to plasma and platelet FVIII/vWF (Fig. 4) . Using unreduced and reduced fibronectin as well as IgM and its aggregates as markers, the apparent molecular weight of the smallest multimer was 0.86 x 106. Multimers of increasing size were separated by a molecular weight interval between 0.8 and 1.1 x 106 (Figs. 4 and 5) 8 .5 x 106), but the largest multimers evident in both normal plasma and normal platelet lysates were not presient (Fig. 3) . Subtype IIB differed from subtype IIA in that intermediatesized multimers were evident in plasmiia. The seventh an(l eighth multimers were easily detectable and, in addition, larger material with average Mr of 8.5 x 106 was usually evident (Fig. 2) . A difference between plasma and platelet FVIII/vWF was observed in subtype IIB. The platelet lysates from all these patients displayed an apparently normal inmultimeric comiiposition (Fig. 3) . The findings in these two subtypes of' variant (type II) VWD were consistent and( reproducible within f;amilies and in samples from the samile patients obtainedl at different times. In cointrai.st to type II, type I VWD patients all demonstrated ac normlllcl multimeric pattern of plasma (Fig. 2) from patients with subtype IIB \a\VD bound at lower concenitrations of ristocetin thani re(quired for normiial FVIII/vWF, in spite of the absence of the larger imolecular forms. In adldition, the miultimiers of IIB FVIII/vWF that bounld at any quantity of ristocetin were smualler than the normal multimiiers that bound at that concentrationi (Fig. 6 ). Platelet FVIII/vWF from IIB patients showed a simnilar enniiciced ristocetininduced binding (Fig. 7) . As with normiial FVIII/vWF, a preferential binding of the largest imultimiiers present was observed at lower quantities of' ristocetini. Plasma of patients with subtype IIA VWD contained only the five smallest multimers and these-like the five smallest multimers in normial plasmta-slhowe(d no appreciable binding at any concenitrationi of ristocetini (Fig. 6 ). The small amounts ofintermediate sized multirmers present in type IIA platelets bound in aI mannier similar to normal platelet FVIII/vWF of the same size (Fig. 7) 
